← Back to Search

Brain Activity Study for Cognitive Impairment in Parkinson's Disease

N/A
Recruiting
Led By Sarah Bick, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age greater than or equal to 40
Scheduled to undergo deep brain stimulation surgery under local anesthesia at Vanderbilt University Medical Center
Must not have
Not able to participate in intraoperative testing (for example unable to comprehend instructions or follow directions)
Age less than 40
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to end of deep brain stimulation (dbs), approximately 3-4 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the brain activity of people with Parkinson's disease in order to better understand the cognitive impairments associated with the condition.

Who is the study for?
This trial is for English-speaking Parkinson's disease patients over 40, who are scheduled for deep brain stimulation surgery at Vanderbilt University Medical Center. Participants must be able to undergo intraoperative testing and have a clinical electrode trajectory that contacts the caudate.
What is being tested?
The study aims to understand cognitive impairment in Parkinson's by recording brain activity from corticostriatal structures during deep brain stimulation surgery. It will measure neural activity associated with nonmotor symptoms of the disease.
What are the potential side effects?
Since this trial involves neurophysiology recordings and neural stimulation during surgery, potential side effects may include typical surgical risks like infection or bleeding, as well as any specific reactions related to deep brain stimulation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 40 years old or older.
Select...
I am scheduled for deep brain stimulation surgery at Vanderbilt under local anesthesia.
Select...
I have been diagnosed with Parkinson's disease.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to follow instructions or directions during surgery.
Select...
I am under 40 years old.
Select...
I have a movement disorder that is not Parkinson's disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of deep brain stimulation (dbs), approximately 3-4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to end of deep brain stimulation (dbs), approximately 3-4 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in caudate DLPFC beta coherence
Nerve Block
Secondary study objectives
Change in beta power with neural stimulation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neural recordings and stimulationExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
905 Previous Clinical Trials
934,024 Total Patients Enrolled
Sarah Bick, MDPrincipal Investigator - Vanderbilt University Medical Center
Vanderbilt University Medical Center
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Neural stimulation Clinical Trial Eligibility Overview. Trial Name: NCT04715984 — N/A
Parkinson's Disease Research Study Groups: Neural recordings and stimulation
Parkinson's Disease Clinical Trial 2023: Neural stimulation Highlights & Side Effects. Trial Name: NCT04715984 — N/A
Neural stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04715984 — N/A
~18 spots leftby Feb 2026